A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3
292
about 3.7 years
12–17
28 sites in AL, AZ, CA +12
About this study
Researchers are testing whether a new asthma treatment called FF/UMEC/VI is better than an existing treatment called FF/VI for children aged 12 to 17 with asthma. The trial will last for about 1361 days and involve around 292 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take FF/UMEC/VI
- 2.Take FF/VI
- 3.Use ELLIPTA
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Change from baseline in trough forced expiratory volume in 1 second (FEV1) (Liters) at Week 24
Secondary: Change from Baseline in Asthma Control Questionnaire (5 items) (ACQ-5) (Scores on a scale), Change from Baseline in Asthma Control Questionnaire (6 items) (ACQ-6) (Scores on a scale), Change from Baseline in Asthma Control Questionnaire (7 items) (ACQ-7) (Scores on a scale), Number of Participants with a clinically important change from baseline in ACQ-5 Score, Number of Participants with a clinically important change from baseline in ACQ-6 Score, Number of Participants with a clinically important change from baseline in ACQ-7 Score
Respiratory